| Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation … Europace 20 (5), 747-757. doi: 10.1093/europace/eux301, 2018 | 144* | 2018 |
| Association between Antithrombotic Treatment and Outcomes at 1-year Follow-Up in Patients with Atrial Fibrillation: The EORP-AF General Long-Term Registry Europace 21 (7), 1013-1022, 2019 | 61* | 2019 |
| Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF … M Proietti, M Vitolo, S Harrison, D Lane, L Fauchier, F Marin, M Nabauer, ... BMC Medicine 19, 256, 2021 | 25 | 2021 |
| The SAMe-TT2R2 score and quality of anticoagulation in atrial fibrillation: a simple aid to decision-making on who is suitable (or not) for vitamin K antagonists L Fauchier, D Angoulvant, GYH Lip EP Europace 17 (5), 671-673, 2015 | 25 | 2015 |
| Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term … WY Ding, M Proietti, G Boriani, L Fauchier, C Blomström-Lundqvist, ... EP Europace 24 (5), 721-728, 2022 | 14 | 2022 |
| Risk factors for recurrence of atrial fibrillation A Kisheva, Y Yotov The Anatolian Journal of Cardiology, DOI: 10.14744/AnatolJCardiol.2020.80914, 2020 | 10 | 2020 |
| Особености в протичането на сърдечната недостатъчност при възрастни пациенти в болнични условия Л Мирчева, А Кишева, А Ангелов, О Кунчев, Й Йотов Списание „Известия на Съюза на учените”–Варна 17, 25-28, 2012 | 10 | 2012 |
| Impact of renal impairment on atrial fibrillation: ESC-EHRA EORP-AF Long-Term General Registry. LGYHKA Ding WY, Potpara TS, Blomström-Lundqvist C, Boriani G, Marin F ... Eur J Clin Invest, 2022 | 9* | 2022 |
| Profiling of cell‐free DNA methylation and histone signatures in pediatric NAFLD: A pilot study D Buzova, MR Braghini, SD Bianco, O Lo Re, M Raffaele, J Frohlich, ... Hepatology communications 6 (12), 3311-3323, 2022 | 8 | 2022 |
| Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC‐EHRA EURObservational research programme in atrial fibrillation general … VL Malavasi, M Vitolo, M Proietti, I Diemberger, L Fauchier, F Marin, ... European journal of clinical investigation 52 (7), e13773, 2022 | 8 | 2022 |
| Quo Vadis, Atherogenesis? Part 1. Smooth Muscle Cell Secretion-How Foe Becomes Friend in the Fight Against the Atherosclerotic Plaque PI Ghenev, L Aloe, AR Kisheva, M Singh, P Panayotov, M Fiore, ... Biomedical Reviews 28, 134-138, 2018 | 7 | 2018 |
| Impact of diabetes on the management and outcomes in atrial fibrillation: an analysis from the ESC-EHRA EORP-AF Long-Term General Registry WY Ding, A Kotalczyk, G Boriani, F Marin, C Blomström-Lundqvist, ... European journal of internal medicine 103, 41-49, 2022 | 6 | 2022 |
| Сърдечна фиброза и роля на галектин-3 в диагностичната и прогностична оценка на сърдечно болните А Кишева, Й Йотов Българска кардиология 4, 14-19, 2012 | 5 | 2012 |
| Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EORP atrial fibrillation general long-term registry M Vitolo, VL Malavasi, M Proietti, I Diemberger, L Fauchier, F Marin, ... European journal of internal medicine 99, 45-56, 2022 | 4 | 2022 |
| Galectin-3 in patients with atrial fibrillation and restored sinus rhythm A Kisheva, Y Yotov, T Chervenkov, A Angelov, Y Bocheva Folia Med (Plovdiv) 63 (3), 329-336, 2021 | 4 | 2021 |
| Atrial fibrillation in cancer patients A Kisheva, L Mircheva Heart-Lung (Varna) 23, 32-36, 2017 | 4 | 2017 |
| Role of fibrosis and blocking of mineralcorticoid receptors in atrial fibrillation A Kisheva PQDT-Global, 2017 | 3 | 2017 |
| Upstream therapy in atrial fibrillation A Kisheva, Y Yotov, A Angelov, A Penev Heart-Lung (Varna) 17 (3-4), 3-13, 2011 | 3 | 2011 |
| Pharmacotherapy of patients with atrial fibrillation and restored sinus rhythm–is the medication with spironolactone beneficial in this case? A Kisheva, Y Yotov, E Grigorov Pharmacia 68, 301, 2021 | 2 | 2021 |
| Does gout matter in patients with atrial fibrillation? A Kisheva, Y Yotov, T Chervenkov, Y Bocheva Journal of interventional cardiac electrophysiology 51 (Supplement 1), S129-S130, 2018 | 2 | 2018 |
Yoto YotovMedical University, VarnaПотвърден имейл адрес: mu-varna.bg
